Drug Discovery and Development

Berkeley Lights names new CEO

By |

Berkeley LightsDigital cell biology firm Berkeley Lights (NSDQ:BLI) has named Dr. Siddhartha Kadia to lead the company.

Founded in 2011, Berkeley Lights has developed a platform that supports the rapid functional characterization of single cells.

To date, the company has raised $272.6t million in funding over nine rounds, according to Crunchbase.

Kadia replaced outgoing CEO Eric Hobbs, who joined the company as senior director, R&D in 2013 and eventually rose to the corner office in 2017.

Siddhartha Kadia

Siddhartha Kadia

Kadia formerly served as president and CEO of EAG Laboratories, a scientific services company.

Before that, he served as president of the life sciences division at Life Technologies Corporation and as a management consultant at McKinsey & Company.

Berkeley Lights also announced that its CFO Kurt Wood has decided to exit the company to pursue a different opportunity. As a result, the company has commenced a search for a replacement.

Filed Under: Biospecimens, Data science
Tagged With: , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

Search Drug Discovery & Development